Xconomy Boston

Neuroptix, Inc. Obtains $18,500,000 Series B Financing

  • Feed Type
  • Date
    10/22/2008
  • Company Name
    Neuroptix, Inc.
  • Mailing Address
    20 Main Street Acton, MA 01720
  • Company Description
    Neuroptix develops, manufactures and distributes state-of-the-art products for extremely sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer’s disease undergoing clinical development. Adaptable and innovative, Neuroptix’s products are designed for a variety of research environments including academic and pharmaceutical laboratories. Neuroptix is also developing diagnostic agents for application in screening tests for Alzheimer’s disease and prion diseases.
  • Website
    http://www.neuroptix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Undisclosed
  • M&A Terms
  • Venture Investor
    Inventages Venture Capital
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.